ascopubs.org

Machine learning-based noninvasive diagnostic classifiers for the prediction of cancer tissue of origin using serum microRNAs.

Observational study examining the feasibility of generating real-world evidence (RWE) for new drug applications from the clinical trials database (DB; RELIASE study). This is an ASCO Meeting Abstract ...
ascopubs.org

Risk stratification using the Decipher 22-gene genomic classifier (GC) and digital pathology artificial intelligence (DPAI) in nearly 10,000 localized prostate cancer patients.

Evaluating molecular alteration profiles to distinguish intraductal carcinoma of the prostate. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does ...